AU2001284891A1 - Micronized leflunomide - Google Patents

Micronized leflunomide

Info

Publication number
AU2001284891A1
AU2001284891A1 AU2001284891A AU8489101A AU2001284891A1 AU 2001284891 A1 AU2001284891 A1 AU 2001284891A1 AU 2001284891 A AU2001284891 A AU 2001284891A AU 8489101 A AU8489101 A AU 8489101A AU 2001284891 A1 AU2001284891 A1 AU 2001284891A1
Authority
AU
Australia
Prior art keywords
leflunomide
micronized
micronized leflunomide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001284891A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Industries Ltd
Original Assignee
Teva Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd filed Critical Teva Pharmaceutical Industries Ltd
Publication of AU2001284891A1 publication Critical patent/AU2001284891A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
AU2001284891A 2000-08-14 2001-08-14 Micronized leflunomide Abandoned AU2001284891A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22537200P 2000-08-14 2000-08-14
US60225372 2000-08-14
PCT/US2001/025417 WO2002013822A1 (en) 2000-08-14 2001-08-14 Micronized leflunomide

Publications (1)

Publication Number Publication Date
AU2001284891A1 true AU2001284891A1 (en) 2002-02-25

Family

ID=22844601

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001284891A Abandoned AU2001284891A1 (en) 2000-08-14 2001-08-14 Micronized leflunomide

Country Status (3)

Country Link
US (2) US20020077485A1 (en)
AU (1) AU2001284891A1 (en)
WO (1) WO2002013822A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001043742A1 (en) * 1999-12-16 2001-06-21 Teva Pharmaceuticals Industries Ltd. Novel processes for making- and a new crystalline form of- leflunomide
DE102005017592A1 (en) * 2005-04-16 2006-10-19 Lindner, Jürgen, Dr. med. Dosage forms and combination preparations of pyrimidine biosynthesis inhibitors to achieve additional effects on the immune system
US7622358B2 (en) * 2005-09-30 2009-11-24 Taiwan Semiconductor Manufacturing Co., Ltd. Semiconductor device with semi-insulating substrate portions and method for forming the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2854439A1 (en) * 1978-12-16 1980-07-03 Hoechst Ag AN ISOXAZOLE DERIVATIVE, METHOD FOR THE PRODUCTION THEREOF, AGENT AND USE THEREOF

Also Published As

Publication number Publication date
US20030032662A1 (en) 2003-02-13
WO2002013822A1 (en) 2002-02-21
US20020077485A1 (en) 2002-06-20

Similar Documents

Publication Publication Date Title
AU2001262847A1 (en) Language-understanding
AU2001292739A1 (en) 1-oxorapamycins
AU2000267458A1 (en) Hypercomputer
AU2001254546A1 (en) Aminopiperidines
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2002211620A1 (en) Autoanastomosis
AU2001258349A1 (en) Bisacylguanidine
AU2001296577A1 (en) Chlorophyllases
AU2001279754A1 (en) Indoloquinazolinones
AU2001281965A1 (en) Novel 6-phenylphenanthridines
AU2002211128A1 (en) Step-bike
AU2001285886A1 (en) 2-guanidino-4-aryl-quinazoline
AU2001290931A1 (en) Ski-snowboard
AU2001293852A1 (en) Sulfonylguanidine
AU2001258924A1 (en) Microsatellite-aflp
AU2002226346A1 (en) 2-aryl-5-trifluoromethylpyridines
AU2001281921A1 (en) Bdellosomes
AU2001291876A1 (en) Triazolo-epothilones
AU2001246864A1 (en) Hypotensors
AU2002214354A1 (en) Neck-phone
AU2001256161A1 (en) Nail
AU2001284891A1 (en) Micronized leflunomide
AU2001295713A1 (en) Blast-processing
AU2001260192A1 (en) Glycinamides